Sujan Dilly Penchala - JoVE Visualize

Showing results (21-30 of 27) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 27 results.

The Journal of Antimicrobial Chemotherapy|May 16, 2021

Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)Carolina Herrera, Julianne Lwanga, Ming Lee, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2021

Total and Unbound Doravirine Concentrations and Viral Suppression in CSFJuan Tiraboschi, Sofia Scévola, Sujan Dilly Penchala, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2022

Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionRichard FitzGerald, Laura Dickinson, Laura Else, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020

Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With TuberculosisAndrew D McCallum, Henry E Pertinez, Laura J Else, et al.

The Journal of Antimicrobial Chemotherapy|July 12, 2024

Clinical, pharmacological, and qualitative characterization of drug-drug interactions in pregnant women initiating HIV therapy in Sub-Saharan AfricaDaniel Kiiza, Danial Rostami-Hochaghan, Yussif Alhassan, et al.

Ebiomedicine|June 16, 2023

Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trialCarolina Herrera, Jennifer Serwanga, Laura Else, et al.

Clinical Pharmacology and Therapeutics|October 26, 2021

An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2Lauren E Walker, Richard FitzGerald, Geoffrey Saunders, et al.

Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 27 results.

The Journal of Antimicrobial Chemotherapy|May 16, 2021

Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)Carolina Herrera, Julianne Lwanga, Ming Lee, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2021

Total and Unbound Doravirine Concentrations and Viral Suppression in CSFJuan Tiraboschi, Sofia Scévola, Sujan Dilly Penchala, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2022

Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionRichard FitzGerald, Laura Dickinson, Laura Else, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020

Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With TuberculosisAndrew D McCallum, Henry E Pertinez, Laura J Else, et al.

The Journal of Antimicrobial Chemotherapy|July 12, 2024

Clinical, pharmacological, and qualitative characterization of drug-drug interactions in pregnant women initiating HIV therapy in Sub-Saharan AfricaDaniel Kiiza, Danial Rostami-Hochaghan, Yussif Alhassan, et al.

Ebiomedicine|June 16, 2023

Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trialCarolina Herrera, Jennifer Serwanga, Laura Else, et al.

Clinical Pharmacology and Therapeutics|October 26, 2021

An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2Lauren E Walker, Richard FitzGerald, Geoffrey Saunders, et al.

Pageof 3